Clinical Trial Update: Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial evaluating Tafluprost-Timolol fixed-dose combination for ocular hypertension and open-angle glaucoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Tafluprost-Timolol fixed-dose combination

Snippet

Sponsor: Santen Oy | Conditions: Ocular Hypertension, Open-angle Glaucoma | Phase 3 | Status: COMPLETED